miércoles, 27 de mayo de 2026
Persistent gaps in skin cancer prevention + + +... +
A multiparameter model (OsteoSC-M3) for early detection and risk stratification of osteoporosis in women: a multicentre cohort study in China
Xiaoyan Tenga,d ∙ Ji Qiaob,d ∙ Yang Xuea ∙ Li Weib ∙ Xiaozhong Jic Send email to 1263830302@qq.com ∙ Yuzhen Du
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00150-1/fulltext?dgcid=raven_jbs_etoc_feature_eclinm
Oropouche virus: transmission, epidemiology, genetic diversity, and public health implications
Lorenzo Subissia Send email to subissil@who.int ∙ James R. Otienoa ∙ Christopher Ruisb,c,d ∙ Ingrid Rabea ∙ Anurag Agrawale ∙ Laith Jamal Abu-Raddadf ∙ et al.
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00118-5/fulltext?dgcid=raven_jbs_etoc_feature_eclinm
May 2026
Volume 95
https://www.thelancet.com/journals/eclinm/issue/vol95nonull/PIIS2589-5370(26)X2004-1
Persistent gaps in skin cancer prevention
eClinicalMedicine
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00255-5/fulltext?dgcid=raven_jbs_etoc_email
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV
https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/whats-new
Update on Statin Therapy as Primary Prevention of Atherosclerotic Cardiovascular Disease in People With HIV
https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/statin-therapy-people-hiv?view=full
Upcoming Regulatory Decision for LNTH-2501 in the Imaging of Neuroendocrine Tumors by Madaline Spencer| Published on: May 26, 2026
Upcoming Regulatory Decision for LNTH-2501 in the Imaging of Neuroendocrine Tumors
by Madaline Spencer| Published on: May 26, 2026
Mauro Cives, MD, Associate Professor of Medical Oncology at the University of Bari, Italy, discusses the upcoming regulatory decision for LNTH-2501 to improve imaging of neuroendocrine tumors (NETs).
https://checkrare.com/upcoming-regulatory-decision-for-lnth-2501-in-the-imaging-of-neuroendocrine-tumors/
Itvisma Gene Therapy for Patients With Spinal Muscular Atrophy by CheckRare Staff| Published on: May 27, 2026
Itvisma Gene Therapy for Patients With Spinal Muscular Atrophy
by CheckRare Staff| Published on: May 27, 2026
John Day, MD, PhD, Director of Neuromuscular Medicine at Stanford University, discusses the development of Itvisma gene therapy for patients with spinal muscular atrophy (SMA).
https://checkrare.com/itvisma-gene-therapy-for-patients-with-spinal-muscular-atrophy/
How multi-omics is changing what scientists can see in the human immune system
https://www.news-medical.net/news/20260429/How-multi-omics-is-changing-what-scientists-can-see-in-the-human-immune-system.aspx?utm_source=azonetwork_newsletter&utm_medium=email&utm_campaign=genomics_newsletter_26_may_2026
By combining high-dimensional immune data with advanced computation, researchers are moving closer to predicting vaccine responses, disease risk, and treatment outcomes, but the field still faces major challenges in data quality, validation, and clinical translation.
New colorectal cancer screening guidelines emphasize advanced stool tests
https://www.news-medical.net/news/20260527/New-colorectal-cancer-screening-guidelines-emphasize-advanced-stool-tests.aspx
With colorectal cancer a growing concern among younger people, the American Cancer Society has endorsed two new types of stool tests to encourage people to get screened while also recommending a limited role for new blood tests many patients find appealing.
Suscribirse a:
Entradas (Atom)

